Skip to main content

Sabeluzole Enhances Spontaneous EEG Activity and SSEP, and Accelerates Their Posthypoxic Recovery in Rat

  • Conference paper
  • 113 Accesses

Abstract

The therapeutic amelioration of ischemia or hypoxia-induced neuronal dysfunction and disability is one of the most important tasks in clinical neurology. A novel drug, Sabeluzole (R 58735), has been shown to improve the posthypoxic survival chances in rats [10], prevent neuronal damage induced by hypoxic insult in rats [9], and antagonize posthypoxic memory deficits in guinea pigs [4]. Apart from these antihypoxic effects, the compound has also been shown to improve learning capacity and memory functions of rats [3], guinea pigs [6], and humans [5]. However, the mechanisms underlying these beneficial effects of Sabeluzole on neuronal functions are not understood. In the present study, we investigated the effects of Sabeluzole on the somatosensory evoked cortical potentials (SSEP) and the spontaneous EEG activities in order to obtain more information about the mode of action of Sabeluzole.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allison T, Hume AL (1981) A comparison analysis of short-latency somatosensory evoked potentials in man, monkey, cat, and rat. Exp Neurol 72:592–611

    Article  PubMed  CAS  Google Scholar 

  2. Ashton D, Fransen JF, Wauquier A (1984) Pharmacological profile of a new antihypoxic and anticonvulsant drug: R56164. Part 2. R56164 produced alterations in bicuculline seizure threshold; a comparison with diphenylhydantoin and carbamazepine. Preclinical Research Report R56164/2, Janssen Pharmaceutica, Beerse, Belgium

    Google Scholar 

  3. Clincke G, Sahgal A (1986) R58735, a novel antihypoxic drug improves memory in rats. Drug Development Research 8:381–385

    Article  CAS  Google Scholar 

  4. Clincke G, Wauquier A (1984) Pharmacological profile of a new antihypoxic and anticonvulsant drug: R56164. Part 5. Antagonism of hypoxia-induced memory deficits and positive effects on learning (acquisition) with R58735 [base of R56164 (HCl)]. Preclinical Research Report R58735/2, Janssen Pharmaceutica, Beerse, Belgium

    Google Scholar 

  5. Clincke GHC, Tritsmans L, Idzikowski C, Amery WK, Janssen PAJ (1988) The effect of R58735 (sabeluzole) on memory functions in healthy elderly volunteers. Psychopharmacology 94:52–57

    Article  PubMed  CAS  Google Scholar 

  6. Clincke GHC, Van Loon J, Wauquier A (1987) The effects of sabeluzole on working memory in a delayed comparison task in the guinea-pig. Preclinical Research Report R58735/16, Janssen Pharmaceutica, Beerse, Belgium.

    Google Scholar 

  7. De Ryck M, Duytschaever H, Clincke GHC, Wauquier A, Janssen PAJ (1989) Anticholinergics reinstate sensorimotor deficits in rats with neocortical damage: protective effects of sabeluzole. Annual Meeting of the Society for Neuroscience, Phoenix, Arizona, October 29-November 3, 1989

    Google Scholar 

  8. Leysen JE, Verwimp M, Gommeren W (1986) In vitro receptor binding and neurotransmitter uptake inhibition profile of the anti-hypoxic agent R58735. Preclinical Research Report R58735/14, Janssen Pharmaceutica, Beerse, Belgium

    Google Scholar 

  9. Van Reempts J, Van Deuren B, Haseldoncks M, Van de Ven M, Borgers M (1986) Structural cell damage and regional blood flow in the hypoxic brain: effects of treatment with R58735, a novel antihypoxic drug. In: Kriegelstein J (ed) Proceedings of the international symposium on pharmacology of cerebral ischemia. Elsevier, Amstendam New York Oxford, pp 385–390

    Google Scholar 

  10. Wauquier A, Clincke G, Ashton D, De Ryck M, Fransen J, Van Clemen G (1986) R58735: a new antihypoxic drug with anticonvulsant properties and possible effects on cognitive functions. Drug Development Research 8:373–380

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Xie, Y. (1991). Sabeluzole Enhances Spontaneous EEG Activity and SSEP, and Accelerates Their Posthypoxic Recovery in Rat. In: Hartmann, A., Kuschinsky, W., Hoyer, S. (eds) Cerebral Ischemia and Dementia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76208-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76208-6_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76210-9

  • Online ISBN: 978-3-642-76208-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics